You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Atomoxetine

Showing 1 - 25 of 235
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

OSA Trial in Boston (Atomoxetine 80 mg plus Oxybutynin 5 mg, Atomoxetine 80 MG, Placebo)

Not yet recruiting
  • OSA
  • Atomoxetine 80 mg plus Oxybutynin 5 mg
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens Hospital
Jul 14, 2023

Obstructive Sleep Apnea Trial in Boston (Atomoxetine, Oxybutynin)

Not yet recruiting
  • Obstructive Sleep Apnea
  • Boston, Massachusetts
    Brigham and Women's Hospital
Sep 19, 2022

ADHD, Dyslexia Trial in New Haven (Atomoxetine, Placebo)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • Dyslexia
  • Atomoxetine
  • Placebo
  • New Haven, Connecticut
    Yale University School of Medicine
Oct 9, 2022

Obstructive Sleep Apnea Trial in Boston (Placebo oral capsule, Atomoxetine Oral Capsule [Strattera])

Recruiting
  • Obstructive Sleep Apnea
  • Placebo oral capsule
  • Atomoxetine Oral Capsule [Strattera]
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 25, 2022

Vasovagal Syncope Trial in Calgary (Atomoxetine Hydrochloride, Placebo)

Recruiting
  • Vasovagal Syncope
  • Atomoxetine Hydrochloride
  • Placebo
  • Calgary, Alberta, Canada
    University of Calgary
Jun 28, 2022

ADHD Trial (Zentiva®, Placebo)

Not yet recruiting
  • Attention Deficit Hyperactivity Disorder
  • (no location specified)
Jan 9, 2023

Tourette Syndrome Trial in Poitiers (Atomoxetine)

Recruiting
  • Tourette Syndrome
  • Atomoxetine
  • Poitiers, France
    CHU Poitiers
Jun 9, 2022

Bariatric Surgery and Pharmacokinetics of Atomoxetine

Recruiting
  • Obesity, Morbid
  • Atomoxetine
  • Trondheim, Norway
    St. Olavs University Hospital
Mar 21, 2022

Obstructive Sleep Apnea, Hypertension Trial in Towson (AD113, Atomoxetine)

Recruiting
  • Obstructive Sleep Apnea
  • Hypertension
  • Towson, Maryland
    PCCAB
Jun 9, 2022

Atomoxetine PBPK-PD Clinical Study

Completed
  • ADHD
  • Atomoxetine Hydrochloride
  • Kansas City, Missouri
    Children's Mercy Hospital and Clinics
Jun 20, 2022

Obstructive Sleep Apnea Trial in Los Angeles, Saint Louis (Dosing 1: Atomoxetine, Dosing 2-4: AD313)

Completed
  • Obstructive Sleep Apnea
  • Dosing 1: Atomoxetine
  • Dosing 2-4: AD313
  • Los Angeles, California
  • +1 more
Oct 3, 2022

Cancer, Cognitive Late Effects Trial in Philadelphia (Atomoxetine)

Withdrawn
  • Cancer
  • Cognitive Late Effects
  • Atomoxetine
  • Philadelphia, Pennsylvania
    Temple University
Mar 30, 2022

Parkinson's Disease, Idiopathic Trial in Cleveland (Methylphenidate, Physical Therapy, Atomoxetine)

Recruiting
  • Parkinson's Disease, Idiopathic
  • Cleveland, Ohio
    Cleveland Clinic
Feb 15, 2022

Schizophrenia Trial in Catonsville (Diet support group, Group counseling and exercise)

Completed
Has Results
  • Schizophrenia
  • Diet support group
  • Group counseling and exercise
  • Catonsville, Maryland
    Maryland Psychiatric Research Center
Mar 1, 2022

Obstructive Sleep Apnea, Down Syndrome Trial in Tucson (Atomoxetine and Oxybutynin (ato-oxy))

Not yet recruiting
  • Obstructive Sleep Apnea
  • Down Syndrome
  • Atomoxetine and Oxybutynin (ato-oxy)
  • Tucson, Arizona
    University of Arizona
Jun 26, 2023

Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)

Active, not recruiting
  • Tachycardia
  • Chronic Orthostatic Intolerance
  • Nashville, Tennessee
    Vanderbilt University Autonomic Dysfunction Center
Sep 12, 2022

OSA Trial (AD109, Placebo)

Not yet recruiting
  • OSA
  • (no location specified)
Apr 12, 2023

OSA Trial (AD109, Placebo)

Not yet recruiting
  • OSA
  • (no location specified)
Apr 13, 2023

Obstructive Sleep Apnea Trial in Boston (Placebo, Acetazolamide, Trazodone)

Not yet recruiting
  • Obstructive Sleep Apnea
  • Placebo
  • +3 more
  • Boston, Massachusetts
    Sleep Disorders Research Program Brigham and Women's Hospital
Jul 18, 2022

Obstructive Sleep Apnea (OSA) Trial (AD109 (atomoxetine/aroxybutynin), Atomoxetine Hydrochloride, Placebo)

Not yet recruiting
  • Obstructive Sleep Apnea (OSA)
  • AD109 (atomoxetine/aroxybutynin)
  • +2 more
  • (no location specified)
Jun 25, 2021

Neurogenic Orthostatic Hypotension Trial in New York, Nashville (Atomoxetine, Placebo)

Active, not recruiting
Has Results
  • Neurogenic Orthostatic Hypotension
  • Atomoxetine
  • Placebo
  • New York, New York
  • +1 more
Aug 22, 2022

Atomoxetine on Brain Imaging, Neuropsychological, and Social

Completed
  • Attention Deficit Hyperactivity Disorder
    • Taipei, Taiwan
      National Taiwan Univeristy Hospital
    Sep 1, 2021

    Obstructive Sleep Apnea, Down Syndrome Trial in Tucson (Atomoxetine and oxybutynin (ato-oxy))

    Recruiting
    • Obstructive Sleep Apnea
    • Down Syndrome
    • Atomoxetine and oxybutynin (ato-oxy)
    • Tucson, Arizona
      University of Arizona
    Sep 27, 2021

    Orthostatic Intolerance Trial in Nashville (Atomoxetine, Placebo)

    Completed
    • Orthostatic Intolerance
    • Atomoxetine
    • Placebo
    • Nashville, Tennessee
      Cyndya Shibao
    Mar 1, 2022

    Neural Mechanisms of Remission in Children With ADHD

    Enrolling by invitation
    • ADHD
    • (no location specified)
    Jan 28, 2022